HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.72% | -3.91% | 23.30% | 9.38% | -25.16% |
| Total Depreciation and Amortization | -13.90% | -25.26% | -20.26% | -9.54% | 21.32% |
| Total Amortization of Deferred Charges | -14.52% | -17.24% | -7.39% | -6.88% | -1.26% |
| Total Other Non-Cash Items | -45.06% | 599.84% | -56.85% | 2.34% | -24.81% |
| Change in Net Operating Assets | -115.03% | 337.91% | 25.15% | -305.77% | -116.94% |
| Cash from Operations | -115.68% | 55.97% | 21.44% | 1.52% | -75.21% |
| Capital Expenditure | -- | 100.00% | -344.44% | 67.86% | 84.33% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.22% | -34.65% | 457.98% | -126.12% | 89.42% |
| Cash from Investing | -207.41% | -35.82% | 463.80% | -126.21% | 92.75% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 36.12% | 66.04% | -178.60% | 5.44% | -459.92% |
| Issuance of Common Stock | -- | -- | -- | -- | 1,942.83% |
| Repurchase of Common Stock | 50.00% | 99.02% | 92.01% | -6,192.59% | -1,057.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -395.22% | 10.99% | -141.67% | 144.30% | -304.17% |
| Cash from Financing | -117.01% | 350.21% | -94.30% | -128.46% | 16,714.93% |
| Foreign Exchange rate Adjustments | -81.78% | 263.36% | -19.09% | -205.56% | -9.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.40% | 453.70% | 71.28% | -276.64% | 896.33% |
